A study for a 53 year old woman who takes Otezla - from FDA reports


3,481 females aged 53 (±5) who take the same drug are studied. This is a personalized study for a 53 year old female patient who has Pustular Psoriasis. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Aug, 19, 2018

3,481 females aged 53 (±5) who take Otezla are studied.


Number of reports submitted per year:

Otezla for a 53-year old woman.

Information of the patient in this study:

  • Age: 53
  • Gender: female
  • Conditions: Pustular Psoriasis
  • Drugs taken:
    • Otezla (apremilast)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Back Pain: 41 (1.18% of females aged 53 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhea
  3. Abdominal pain
  4. Insomnia (sleeplessness)
  5. Joint pain
  6. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Mood swings (an extreme or rapid change in mood)
  9. Muscle spasms (muscle contraction)
  10. Stress and anxiety
1 - 6 months:
  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhea
  3. Headache (pain in head)
  4. Drug ineffective
  5. Psoriasis (immune-mediated disease that affects the skin)
  6. Depression
  7. Nausea and vomiting
  8. Abdominal discomfort
  9. Upper respiratory tract infection
  10. Insomnia (sleeplessness)
6 - 12 months:
  1. Nausea (feeling of having an urge to vomit)
  2. Drug ineffective
  3. Diarrhea
  4. Psoriasis (immune-mediated disease that affects the skin)
  5. Headache (pain in head)
  6. Depression
  7. Nausea and vomiting
  8. Fatigue (feeling of tiredness)
  9. Pain in extremity
  10. Weight decreased
1 - 2 years:
  1. Drug ineffective
  2. Abdominal discomfort
  3. Headache (pain in head)
  4. Rashes (redness)
  5. Upper respiratory tract infection
  6. Depression
  7. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  8. Anorectal discomfort
  9. Death
  10. Migraine (headache)
2 - 5 years:
  1. Diarrhea
  2. Abdominal pain
5 - 10 years:
  1. Diarrhea
10+ years:
n/a
not specified:
  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhea
  3. Headache (pain in head)
  4. Psoriasis (immune-mediated disease that affects the skin)
  5. Drug ineffective
  6. Abdominal discomfort
  7. Nausea and vomiting
  8. Weight decreased
  9. Depression
  10. Abdominal pain upper

Top conditions involved for these people *:

  1. Psoriasis (immune-mediated disease that affects the skin): 1,679 people, 48.23%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1,489 people, 42.78%
  3. High Blood Pressure : 80 people, 2.30%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 61 people, 1.75%
  5. Pain : 53 people, 1.52%
  6. Depression : 43 people, 1.24%
  7. Diabetes : 40 people, 1.15%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 40 people, 1.15%
  9. High Blood Cholesterol : 37 people, 1.06%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 36 people, 1.03%

Top co-used drugs for these people *:

  1. Vitamin D (144 people, 4.14%)
  2. Methotrexate (138 people, 3.96%)
  3. Enbrel (108 people, 3.10%)
  4. Synthroid (107 people, 3.07%)
  5. Metformin (90 people, 2.59%)
  6. Humira (85 people, 2.44%)
  7. Cymbalta (66 people, 1.90%)
  8. Nexium (50 people, 1.44%)
  9. Calcium (49 people, 1.41%)
  10. Xanax (48 people, 1.38%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:



Related studies:

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!